Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepcidin and anaemia.

Robert T Means1

  • 1Hematology/Oncology Division, Department of Medicine, Ralph H. Johnson VA Medical Center and the Medical University of South Carolina, 903 CSB, 96 Jonathan Lucas Street, Charleston, SC 29425, USA. meansr@musc.edu

Blood Reviews
|October 27, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Somatic Mutations in Acquired Pure Red Cell Aplasia: Incidence and Implications.

American journal of hematology·2026
Same author

Macrocytes in hemochromatosis: associations of a common finding in a common disease.

The American journal of the medical sciences·2026
Same author

Management of iron deficiency in children, adults, and pregnant individuals: evidence-based and expert consensus recommendations.

The Lancet. Haematology·2025
Same author

Ferritin reference intervals in a population of working-age adults without anemia.

American journal of hematology·2024
Same author

New molecular approaches to "the first molecular disease".

Journal of investigative medicine : the official publication of the American Federation for Clinical Research·2024
Same author

Pure red cell aplasia: The second hundred years.

The American journal of the medical sciences·2023
Same journal

Treating large B-cell lymphoma: Current strategies and unmet needs across community and academic settings.

Blood reviews·2026
Same journal

MRD in multiple myeloma: Moving from "minimal" to "measurable".

Blood reviews·2026
Same journal

PRISMA-based systematic review on iron stores in repeat blood donors.

Blood reviews·2026
Same journal

Artificial intelligence applications in thrombotic thrombocytopenic Purpura: A systematic review of diagnostic, risk stratification, and prognostic models.

Blood reviews·2026
Same journal

Antibacterial, antifungal and antiviral prophylaxis and vaccination strategies in adult patients with acute myeloid and promyelocytic leukemia: An expert panel consensus from the GIMEMA group.

Blood reviews·2026
Same journal

The Lebanese national patient blood management guidelines: A new page in the medical practice.

Blood reviews·2026
See all related articles

The anaemia of chronic disease (ACD) involves iron metabolism issues, often with high ferritin. Hepcidin, a key iron regulator, is likely a major cause of these characteristic iron abnormalities.

Area of Science:

  • Hematology
  • Iron Metabolism
  • Molecular Biology

Background:

  • Anaemia of chronic disease (ACD) is a common condition with low iron in the blood but sufficient iron stores.
  • Elevated serum ferritin is frequently observed in ACD patients.
  • ACD pathogenesis involves complex interactions affecting red blood cell survival, erythropoiesis, and iron regulation.

Purpose of the Study:

  • To investigate the role of hepcidin in the pathogenesis of anaemia of chronic disease.
  • To explore the relationship between hepcidin levels and iron parameters in ACD.
  • To determine if hepcidin is a key mediator of ACD-related iron abnormalities.

Main Methods:

  • Analysis of hepcidin production in serum and urine.
  • Correlation of hepcidin concentrations with serum ferritin levels.

Related Experiment Videos

  • Comparison of hepcidin levels in ACD versus iron deficiency.

    • Main Results:

    • Hepcidin production shows a strong correlation with serum ferritin concentration in ACD.
    • Hepcidin is identified as a key regulator of iron balance.
    • Abnormal hepcidin gene expression is linked to altered iron parameters and anaemia.

    Conclusions:

    • Hepcidin is strongly implicated as a major contributor to the characteristic iron abnormalities in anaemia of chronic disease.
    • Further research is needed to ascertain hepcidin's broader role in ACD pathogenesis.
    • Hepcidin's function as an acute-phase reactant protein is relevant to its role in ACD.